INS and diabetes mellitus: Oral administration of mature CW in diabetic rats showed a significant reduction in blood glucose and glycated hemoglobin levels, with an improvement in plasma insulin levels, which exerted significant antihyperglycemic potential and could be developed as a potent drug candidate or nutraceutical for the management of diabetes and associated complications [32].